Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.
Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas M, Ahmed SO, Novitzky N, Srivastava A, Seber A, Elsolh H, Ghavamzadeh A, Confer D, Kodera Y, Greinix H, Szer J, Horowitz M, Niederwieser D. Aljurf M, et al. Among authors: hamladji rm. Hematol Oncol Stem Cell Ther. 2020 Mar;13(1):7-16. doi: 10.1016/j.hemonc.2019.08.002. Epub 2019 Aug 20. Hematol Oncol Stem Cell Ther. 2020. PMID: 31449781 Free article.
Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.
Mohamed SY, Fadhil I, Hamladji RM, Hamidieh AA, Fahmy O, Ladeb S, Alimoghaddam K, Elhaddad A, Nacer RA, Alsharif F, Rasheed W, Jahani M, Mousavi SA, Alseraihy A, Abdel-Rahman F, Al Jefri A, Hussein AA, Alabdulaaly A, Ibrahim A, Bekadja MA, Abboud M, Ahmed P, Dennison D, Bakr M, Benchekroun S, Hussain F, Othman TB, Aljurf M, Ghavamzadeh A. Mohamed SY, et al. Among authors: hamladji rm. Hematol Oncol Stem Cell Ther. 2011;4(2):81-93. doi: 10.5144/1658-3876.2011.81. Hematol Oncol Stem Cell Ther. 2011. PMID: 21727769 Free article.
A population-based study of the epidemiology and clinical features of adults with acute myeloid leukemia in Algeria: report on behalf of the Algerian Acute Leukemia Study Group.
Bekadja MA, Hamladji RM, Belhani M, Ardjoun FZ, Abad MT, Touhami H, Ait-Ali H, Zouaoui Z, Sidimansour N, Hamdi S, Grifi F, Mesli N, Saidi M, Mehalhal N, Bachiri A, Bouhass R, Said YM, Midoun N. Bekadja MA, et al. Among authors: hamladji rm. Hematol Oncol Stem Cell Ther. 2011;4(4):161-6. doi: 10.5144/1658-3876.2011.161. Hematol Oncol Stem Cell Ther. 2011. PMID: 22198187 Free article.
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Rasheed W, Ghavamzadeh A, Hamladji R, Ben Othman T, Alseraihy A, Abdel-Rahman F, Elhaddad A, Alabdulaaly A, Dennison D, Ibrahim A, Bazarbachi A, Bekadja MA, Mohamed SY, Adil SN, Ahmed P, Benchekroun S, Ramzi M, Jarrar M, Alimoghaddam K, Hussain F, Hamidieh A, Aljurf M. Rasheed W, et al. Hematol Oncol Stem Cell Ther. 2013 Mar;6(1):14-9. doi: 10.1016/j.hemonc.2013.04.001. Epub 2013 Apr 6. Hematol Oncol Stem Cell Ther. 2013. PMID: 23664600 Free article.
Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia?
Ringdén O, Labopin M, Solders M, Beelen D, Arnold R, Ehninger G, Milpied N, Niederwieser D, Hamladji RM, Kyrcz-Krzemien S, Ganser A, Socié G, Stelljes M, Volin L, Craddock C, Mohty M; Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Ringdén O, et al. Among authors: hamladji rm. Transplantation. 2014 Sep 15;98(5):569-77. doi: 10.1097/TP.0000000000000102. Transplantation. 2014. PMID: 24798307
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.
Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Hamladji RM, Blaise D, Socié G, Lioure B, Bermudez A, Lopez-Corral L, Or R, Arcese W, Fegueux N, Nagler A, Mohty M. Kharfan-Dabaja MA, et al. Among authors: hamladji rm. Bone Marrow Transplant. 2014 Sep;49(9):1170-5. doi: 10.1038/bmt.2014.133. Epub 2014 Jun 30. Bone Marrow Transplant. 2014. PMID: 24978140
Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Socie G, Kroeger N, Blaise D, Veelken H, Bermudez A, Or R, Lioure B, Beelen D, Fegueux N, Hamladji RM, Nagler A, Mohty M. Kharfan-Dabaja MA, et al. Among authors: hamladji rm. Leuk Res. 2015 Sep;39(9):933-7. doi: 10.1016/j.leukres.2015.04.009. Epub 2015 Apr 24. Leuk Res. 2015. PMID: 26003666
Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M, Nassar A, Hamidieh AA, Elhaddad A, Hamladji RM, Bazarbachi A, Ibrahim A, Ben Othman T, Abdel-Rahman F, Alseraihy A, Fahmy O, Hussein AA, Alabdulaaly A, Adil S, Alkindi SS, Bayoumy M, Dennison D, Bekadja MA, Redhouane AN, Rasheed W, AlSagheir A, Alsudairy R, Ladeb S, Benchekroun S, Ramzi M, Ahmed P, ElSolh H, Ahmed SO, Hussain F, Ghavamzadeh A. Aljurf M, et al. Among authors: hamladji rm. Hematol Oncol Stem Cell Ther. 2015 Dec;8(4):167-75. doi: 10.1016/j.hemonc.2015.09.002. Epub 2015 Oct 1. Hematol Oncol Stem Cell Ther. 2015. PMID: 26452331 Free article.
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
Rubio MT, D'Aveni-Piney M, Labopin M, Hamladji RM, Sanz MA, Blaise D, Ozdogu H, Daguindeau E, Richard C, Santarone S, Irrera G, Yakoub-Agha I, Yeshurun M, Diez-Martin JL, Mohty M, Savani BN, Nagler A. Rubio MT, et al. Among authors: hamladji rm. J Hematol Oncol. 2017 Jan 24;10(1):31. doi: 10.1186/s13045-016-0389-4. J Hematol Oncol. 2017. PMID: 28118857 Free PMC article.
62 results